Latest news for Genetic Technologies (OTC:GNTLF) Stock

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

GENETIC TECHS LTD by Genetic Technologies Ltd.

Genetic Technologies Ltd

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has extended the closing date for its Entitlement Offer and prol...

Genetic Technologies Extends Offer and Suspends Trading

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced an extension of the Shortfall Offer under its Enti...

Genetic Technologies Extends Securities Offer Deadline

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has appointed voluntary administrators after failing to secure s...

Genetic Technologies Enters Voluntary Administration

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited, currently under administration, has withdrawn its rights issue ...

Genetic Technologies Withdraws Offer Amid Strategic Review

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has cancelled its previously announced Entitlement Offer Prospec...

Genetic Technologies Cancels Entitlement Offer Plans

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has announced the return of $324,648 in subscription monies and ...

Genetic Technologies Halts Offers, Returns Funds Amid Compliance Scrutiny

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited, a prominent player in genomics-based diagnostics, has announced...

Genetic Technologies Defers Reports Amid Administration

Genetic Technologies (AU:GTG) has released an update. Rhythm Biosciences Ltd has acquired the Genetype genetic risk assessment business, enhancing ...

Rhythm Biosciences Expands with Genetype Acquisition

Genetic Technologies (AU:GTG) has released an update. Genetic Technologies Limited has successfully completed the sale of its geneType business and...

Genetic Technologies Sells geneType Business to Rhythm Biosciences

Genetic Technologies ( ($AU:GTG) ) has shared an announcement. Genetic Technologies Limited has announced an agreement to sell its Direct-to-Consum...

Comments

Genetic Technologies

News

Latest news for Genetic Technologies (OTC:GNTLF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga